Consumer health companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list PReye with 1 drug recall and 1 warning letter. The most recent is a warning letter dated Aug 18, 2026: Warning letter: Aseptic processing, Sterility assurance, Supplier controls.
Drug approvals, 510(k) clearances, recalls and letters, 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Aug 18, 2026 | Warning letter: Aseptic processing, Sterility assurance, Supplier controlsCDER | Warning letter |
| May 18, 2026 | PReye Vitamin See Antioxidant Preservative Free Eye Drops, Distributed by: PReye, LLC, Golden, COClass II · Lack of Assurance of Sterility | Drug recall |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.